Showing 1-5 of 53 webinars:
Integrated Evidence Generation: Exploring Registries in the Era of Automation

Thu, Mar 28, 2024 2:00 PM – 3:00 PM EDT Presenters: Sonja Wustrack, MPH, Managing Director, Integrated Evidence Generation and Michelle Leavy, MPH Director, Real-World Evidence Strategy Register >> Integrated evidence generation is gaining traction in the biopharmaceutical industry as an approach to aligning evidence needs across functions within a company. Real-world data and real-world[…]

AI and Digital Phenotyping for Clinical Development

Wed, Jan 31, 2024 2:00 PM – 3:00 PM EST Register here >> With the new year comes even more hype with how AI will transform the healthcare and pharmaceutical landscape – including McKinsey estimating that AI technology could generate up to $110 billion a year in economic value for the pharma and medical-product industries.[…]

Shifting the Paradigm (and Prince)on Integrated Evidence Generation

MAPS Webinar 9/15/23 Listen tot he full webianr >> Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]

Using AI to Expand Treatment Access and Close Guideline Gaps

Tue, Jun 20, 2023 11:00 AM – 12:00 PM EDT Presenters: Costas Boussios, Chief Data Scientist and Joseph Zabinski, Managing Director of AI & Personalized Medicine Register>> Across many conditions, screening for diagnosis and use of effective therapies remain far behind where best-practice clinical guidelines would suggest. Patients falling into this ‘guidelines gap’ may not[…]

1 2 3 11